Combined retinal artery and vein occlusions associated with interferon beta therapy;Kombinierter retinaler arteriovenöser Verschluss unter Interferon-β-Therapie

Ophthalmologe

Volumn 109, Issue 1, 2012, Pages 71-75

  Jenisch, T ^a   Dietrich Ntoukas, T ^a   Renner, A B ^a   Helbig, H ^a   Gamulescu, M A ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Interferon beta; Multiple sclerosis; Retinal artery occlusion; Retinal vein occlusion; Retinopathy

Indexed keywords

BETA INTERFERON; IMMUNOLOGIC FACTOR;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; MULTIPLE SCLEROSIS; RETINA ARTERY OCCLUSION; RETINA VEIN OCCLUSION;

ADULT; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; MULTIPLE SCLEROSIS; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION;

EID: 84856218625     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-011-2448-0     Document Type: Article

References (10)

1. Guyer DR, Tiedeman J, Yannuzzi LA et al (1993) Interferon-associated retinopathy. Arch Ophthalmol 111(3): 350-356.
2. Hayasaka S, Nagaki Y, Matsumoto M, Sato S (1998) Interferon associated retinopathy. Br J Ophthalmol 82(3): 323-325.
3. Jain K, Lam WC, Waheeb S et al (2001) Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin. Br J Ophthalmol 85(10): 1171-1173.
4. Jongen PJ, Sindic C, Carton H et al (2010) Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a. J Neurol 257(4): 584-589.
5. Rubio JE, Charles S (2003) Interferon-associated combined branch retinal artery and central retinal vein obstruction. Retina 23(4): 546-548.
6. Kappos L, Traboulsee A, Constantinescu C et al (2006) Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS. Neurology 67(6): 944-953.
7. Novick D, Cohen B, Rubinstein M (1994) The human interferon alpha/beta receptor. Characterization and molecular cloning. Cell 77(3): 391-400.
8. Ohira M, Ito D, Shimizu T et al (2009) Retinopathy: an overlooked adverse effect of interferon-beta treatment of multiple sclerosis. Keio J Med 58(1): 54-569.
9. Sugano S, Suzuki T, Watanabe M et al (1998) Retinal complications with elevated circulating plasma C5a associated with interferon-alpha-therapy for chronic active hepatitis C. Am J Gastroenterol 93(12): 2441-2444.
10. Taniguchi T, Mantei N, Schwarzenstein M et al (1980) Human leukocyte and fibroblast interferons are structurally related. Nature 285(5766): 547-549.